Amin MB, Berney DM, Compérat, EM, et al. Tumours of the kidney. In: WHO Classification of Tumours Editorial Board. Urinary and male genital tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2022 [cited 2022/8/6]. (WHO classification of tumours series, 5th ed.; vol. 8). Available from: https://tumourclassification.iarc.who.int/chapters/36.

Uhrig S, Ellermann J, Walther T, Burkhardt P, Fröhlich M, Hutter B, Toprak UH, Neumann O, Stenzinger A, Scholl C, Fröhling S, Brors B (2021) Accurate and efficient detection of gene fusions from RNA sequencing data. Genome Res 31:448–460. https://doi.org/10.1101/gr.257246.119

Article  PubMed  PubMed Central  Google Scholar 

Morris SW, Kirstein MN, Valentine MB, Dittmer K, Shapiro DN, Look AT, Saltman DL (1995) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma. Science 267:316–317. https://doi.org/10.1126/science.267.5196.316-b

Article  CAS  PubMed  Google Scholar 

Gunby RH, Sala E, Tartari CJ, Puttini M, Gambacorti-Passerini C, Mologni L (2007) Oncogenic fusion tyrosine kinases as molecular targets for anti-cancer therapy. Anticancer Agents Med Chem 7:594–611. https://doi.org/10.2174/187152007784111340

Article  CAS  PubMed  Google Scholar 

Kuroda N, Trpkov K, Gao Y, Tretiakova M, Liu YJ, Ulamec M, Takeuchi K, Agaimy A, Przybycin C, Magi-Galluzzi C, Fushimi S, Kojima F, Sibony M, Hang JF, Pan CC, Yilmaz A, Siadat F, Sugawara E, Just PA, Ptakova N, Hes O (2020) ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217. Mod Pathol 33:2564–2579. https://doi.org/10.1038/s41379-020-0578-0

Article  CAS  PubMed  Google Scholar 

Tao JJ, Wei G, Patel R, Fagan P, Hao X, Bridge JA, Arcila ME, Al-Ahmadie H, Lee CH, Li G, Drilon A (2018) ALK fusions in renal cell carcinoma: response to entrectinib. JCO Precis Oncol 2:1–8. https://doi.org/10.1200/PO.18.00185

Article  PubMed  Google Scholar 

Wang XT, Fang R, Ye SB, Zhang RS, Li R, Wang X, Ji RH, Lu ZF, Ma HH, Zhou XJ, Xia QY, Rao Q (2019) Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: a unique case from an older patient without clinical evidence of sickle cell trait. Pathol Res Pract 215:152651. https://doi.org/10.1016/j.prp.2019.152651

Article  CAS  PubMed  Google Scholar 

Sangoi AR, Kimm SY, Chan E. VCL-ALK renal cell carcinoma in adult patient without sickle cell trait (2021) Human Pathology: Case Reports 25:200528

Debelenko LV, Raimondi SC, Daw N, Shivakumar BR, Huang D, Nelson M, Bridge JA (2011) Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum. Mod Pathol 24:430–442. https://doi.org/10.1038/modpathol.2010.213

Article  CAS  PubMed  Google Scholar 

Mariño-Enríquez A, Ou WB, Weldon CB, Fletcher JA, Pérez-Atayde AR (2011) ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chromosomes Cancer 50:146–153. https://doi.org/10.1002/gcc.20839

Article  CAS  PubMed  Google Scholar 

Sugawara E, Togashi Y, Kuroda N, Sakata S, Hatano S, Asaka R, Yuasa T, Yonese J, Kitagawa M, Mano H, Ishikawa Y, Takeuchi K (2012) Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method. Cancer 118:4427–4436. https://doi.org/10.1002/cncr.27391

Article  CAS  PubMed  Google Scholar 

Smith NE, Deyrup AT, Mariño-Enriquez A, Fletcher JA, Bridge JA, Illei PB, Netto GJ, Argani P (2014) VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy? Am J Surg Pathol 38:858–863. https://doi.org/10.1097/PAS.0000000000000179

Article  PubMed  PubMed Central  Google Scholar 

Thorner PS, Shago M, Marrano P, Shaikh F, Somers GR (2016) TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: report of a case with a TPM3-ALK translocation. Pathol Res Pract 212:937–942. https://doi.org/10.1016/j.prp.2016.07.004

Article  CAS  PubMed  Google Scholar 

Kusano H, Togashi Y, Akiba J, Moriya F, Baba K, Matsuzaki N, Yuba Y, Shiraishi Y, Kanamaru H, Kuroda N, Sakata S, Takeuchi K, Yano H (2016) Two cases of renal cell carcinoma harboring a novel STRN-ALK fusion gene. Am J Surg Pathol 40:761–769. https://doi.org/10.1097/PAS.0000000000000610

Article  PubMed  Google Scholar 

Cajaiba MM, Jennings LJ, Rohan SM, Perez-Atayde AR, Marino-Enriquez A, Fletcher JA, Geller JI, Leuer KM, Bridge JA, Perlman EJ (2016) ALK-rearranged renal cell carcinomas in children. Genes Chromosomes Cancer 55:442–451. https://doi.org/10.1002/gcc.22346

Article  CAS  PubMed  Google Scholar 

Cajaiba MM, Jennings LJ, George D, Perlman EJ (2016) Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: identification of a novel HOOK1-ALK fusion transcript. Genes Chromosomes Cancer 55:814–817. https://doi.org/10.1002/gcc.22382

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu W, Wang Y, Jiang Y, Zhang W, Li Y (2017) Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review. Histopathology 71:53–62. https://doi.org/10.1111/his.13185

Article  PubMed  Google Scholar 

Ross JS, Ali SM, Fasan O, Block J, Pal S, Elvin JA, Schrock AB, Suh J, Nozad S, Kim S, Jeong Lee H, Sheehan CE, Jones DM, Vergilio JA, Ramkissoon S, Severson E, Daniel S, Fabrizio D, Frampton G, Miller VA, Stephens PJ, Gay LM (2017) ALK fusions in a wide variety of tumor types respond to anti-ALK targeted therapy. Oncologist 22:1444–1450. https://doi.org/10.1634/theoncologist.2016-0488

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bodokh Y, Ambrosetti D, Kubiniek V, Tibi B, Durand M, Amiel J, Pertuit M, Barlier A, Pedeutour F (2018) ALK-TPM3 rearrangement in adult renal cell carcinoma: report of a new case showing loss of chromosome 3 and literature review. Cancer Genet 221:31–37. https://doi.org/10.1016/j.cancergen.2017.11.010

Article  CAS  PubMed  Google Scholar 

Pal SK, Bergerot P, Dizman N, Bergerot C, Adashek J, Madison R, Chung JH, Ali SM, Jones JO, Salgia R (2018) Responses to alectinib in ALK-rearranged papillary renal cell carcinoma. Eur Urol 74:124–128. https://doi.org/10.1016/j.eururo.2018.03.032

Article  PubMed  Google Scholar 

Yang J, Dong L, Du H, Li XB, Liang YX, Liu GR (2019) ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature review. Diagn Pathol 18(14):112. https://doi.org/10.1186/s13000-019-0879-0

Article  CAS  Google Scholar 

Hang JF, Chung HJ, Pan CC (2020) ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology. Virchows Arch 476:921–929. https://doi.org/10.1007/s00428-020-02752-5

Article  CAS  PubMed  Google Scholar 

Woo CG, Yun SJ, Son SM, Lim YH, Lee OJ (2020) Characteristics of renal cell carcinoma harboring TPM3-ALK fusion. Yonsei Med J 61:262–266. https://doi.org/10.3349/ymj.2020.61.3.262

Article  PubMed  PubMed Central  Google Scholar 

Zhu Y, Liu N, Guo W, Pu X, Guo H, Gan W, Li D (2020) ALK rearrangement in TFE3-positive renal cell carcinoma: alternative diagnostic option to exclude Xp11.2 translocation carcinoma. Pathol Res Pract 216:153286. https://doi.org/10.1016/j.prp.2020.153286

Article  CAS  PubMed  Google Scholar 

Wangsiricharoen S, Zhong M, Ranganathan S, Matoso A, Argani P (2021) ALK-rearranged renal cell carcinoma (RCC): a report of 2 cases and review of the literature emphasizing the distinction between VCL-ALK and non-VCL-ALK RCC. Int J Surg Pathol 29:808–814. https://doi.org/10.1177/10668969211003660

Article  CAS  PubMed  Google Scholar 

Kai K, Tobu S, Kido S, Mikami S, Takeuchi K, Dobashi A, Togashi Y, Noguchi M, Aishima S (2022) ALK rearrangement-associated renal cell carcinoma morphologically mimicking mucinous tubular and spindle cell carcinoma: a case report. Diagn Pathol 17:52. https://doi.org/10.1186/s13000-022-01238-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lindeman NI, Cagle PT, Aisner DL et al (2018) Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. Arch Pathol Lab Med 142:321–346. https://doi.org/10.5858/arpa.2017-0388-CP

Article  CAS  PubMed  Google Scholar